Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
暂无分享,去创建一个
[1] C. Liu,et al. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma. , 2019, Urologic oncology.
[2] Winnie S. Liang,et al. A virome-wide clonal integration analysis platform for discovering cancer viral etiology , 2019, Genome research.
[3] J. Shay,et al. Telomeres and telomerase: three decades of progress , 2019, Nature Reviews Genetics.
[4] F. Westermann,et al. A mechanistic classification of clinical phenotypes in neuroblastoma , 2018, Science.
[5] S. Imbeaud,et al. Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress , 2018, Nature Communications.
[6] Trevor J Pugh,et al. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer , 2018, The Journal of clinical investigation.
[7] T. Ekström,et al. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma. , 2018, Cancer letters.
[8] C. Larsson,et al. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression , 2018, Oncogene.
[9] Jun S. Song,et al. Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner. , 2018, Cancer cell.
[10] Julie M. Batten,et al. DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome , 2018, Acta Neuropathologica.
[11] V. Gladyshev,et al. Mechanisms of cancer resistance in long-lived mammals , 2018, Nature Reviews Cancer.
[12] Mazen A. Juratli,et al. TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study , 2018, Clinical Cancer Research.
[13] R. McLendon,et al. The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma , 2018, Nature Communications.
[14] O. Larsson,et al. Telomerase promoter mutations and copy number alterations in solitary fibrous tumours , 2018, Journal of Clinical Pathology.
[15] P. A. Futreal,et al. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal , 2018, Cell.
[16] M. Mahajan,et al. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma , 2018, Oncogene.
[17] C. Larsson,et al. Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma , 2018, Clinical endocrinology.
[18] C. Larsson,et al. TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker. , 2017, The oncologist.
[19] X. Darzacq,et al. Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism , 2017, Science.
[20] J. Yoon,et al. Human Telomerase Reverse Transcriptase (hTERT) Positively Regulates 26S Proteasome Activity , 2017, Journal of cellular physiology.
[21] Kai-Ping Chang,et al. Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma , 2017, Head & neck.
[22] Dawei Xu,et al. WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERThigh Prostate Cancer Stem Cells. , 2017, Cancer research.
[23] Michael C. Ostrowski,et al. The ETS family of oncogenic transcription factors in solid tumours , 2017, Nature Reviews Cancer.
[24] Richard C. Wang,et al. Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations , 2017, The Journal of clinical investigation.
[25] Dawei Xu,et al. The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma , 2017, Oncotarget.
[26] Xin Hu,et al. Systematic analysis of telomere length and somatic alterations in 31 cancer types , 2017, Nature Genetics.
[27] J. Shay,et al. Regulation of the Human Telomerase Gene TERT by Telomere Position Effect—Over Long Distances (TPE-OLD): Implications for Aging and Cancer , 2016, PLoS biology.
[28] L. Saft,et al. TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations , 2016, Annals of Hematology.
[29] Dawei Xu,et al. Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications , 2016, Genes.
[30] J. Shay,et al. hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor , 2016, Nucleic acids research.
[31] K. Aldape,et al. TERT Promoter Mutations and Risk of Recurrence in Meningioma. , 2016, Journal of the National Cancer Institute.
[32] Xiaoming Li,et al. Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis , 2016, Molecular Neurobiology.
[33] Jun S. Song,et al. Understanding TERT Promoter Mutations: A Common Path to Immortality , 2016, Molecular Cancer Research.
[34] Bert Vogelstein,et al. The Path to Cancer --Three Strikes and You're Out. , 2015, The New England journal of medicine.
[35] D. Zwijnenburg,et al. Abstract PR06: TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors , 2016 .
[36] B. Vogelstein,et al. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers , 2015, Genes & development.
[37] Y. Maida,et al. Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase , 2015, Cancer science.
[38] Simon C Watkins,et al. Telomerase activation by genomic rearrangements in high-risk neuroblastoma , 2015, Nature.
[39] F. He,et al. hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation , 2015, Gut.
[40] Jessica Zucman-Rossi,et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas , 2015, Nature Genetics.
[41] Z. Cai,et al. The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer , 2015, Oncotarget.
[42] J. Boyle,et al. Cancer-associated TERT promoter mutations abrogate telomerase silencing , 2015, eLife.
[43] Chibo Hong,et al. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer , 2015, Science.
[44] C. Liu,et al. TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer. , 2015, The oncologist.
[45] Christophe Simon,et al. Telomerase Reverse Transcriptase Regulates microRNAs , 2015, International journal of molecular sciences.
[46] G. Saretzki. Extra-telomeric functions of human telomerase: cancer, mitochondria and oxidative stress. , 2014, Current pharmaceutical design.
[47] C. Larsson,et al. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas , 2014, Oncogene.
[48] V. Dosenko,et al. Silencing of TERT decreases levels of miR‐1, miR‐21, miR‐29a and miR‐208a in cardiomyocytes , 2014, Cell biochemistry and function.
[49] J. Shay,et al. Alternative splicing regulation of telomerase: a new paradigm? , 2014, Trends in genetics : TIG.
[50] C. Larsson,et al. TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma , 2014, Oncotarget.
[51] Lawrence A. Donehower,et al. The somatic genomic landscape of chromophobe renal cell carcinoma. , 2014, Cancer cell.
[52] J. Bishop,et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] C. Larsson,et al. Telomerase-Dependent and Independent Telomere Maintenance and its Clinical Implications in Medullary Thyroid Carcinoma , 2014, The Journal of clinical endocrinology and metabolism.
[54] Robert Tjian,et al. Looping Back to Leap Forward: Transcription Enters a New Era , 2014, Cell.
[55] M. Knowles,et al. Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. , 2014, European urology.
[56] Junzhi Zhou,et al. Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF‐κB‐dependent transcription , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] J. Shay,et al. Endoplasmic reticulum stress activates telomerase , 2013, Aging cell.
[58] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[59] J. Yang,et al. Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells , 2013, Oncogene.
[60] David T. W. Jones,et al. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. , 2013, The Lancet. Oncology.
[61] C. Bokemeyer,et al. Molecular characterization of chromosomal band 5p15.33: a recurrent breakpoint region in mantle cell lymphoma involving the TERT-CLPTM1L locus. , 2013, Leukemia research.
[62] R. Janzer,et al. Methylation of the hTERT Promoter: A Novel Cancer Biomarker for Leptomeningeal Metastasis Detection in Cerebrospinal Fluids , 2013, Clinical Cancer Research.
[63] D. Schadendorf,et al. TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.
[64] Lynda Chin,et al. Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2013, Science.
[65] Angela M. Liu,et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma , 2012, Nature Genetics.
[66] M. Pagel,et al. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination , 2011, Aging cell.
[67] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[68] T. Tollefsbol,et al. Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[69] R. Janzer,et al. Abstract 4931: Methylation of the hTERT promoter: a potential cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids , 2010 .
[70] S. Grigoryev,et al. Rearrangement of upstream sequences of the hTERT gene during cellular immortalization , 2009, Genes, chromosomes & cancer.
[71] M. Björkholm,et al. FoxM1 is up‐regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27kip1 , 2009, The Journal of pathology.
[72] Timothy D. Veenstra,et al. Telomerase modulates Wnt signalling by association with target gene chromatin , 2009, Nature.
[73] S. Kyo,et al. Activation of telomerase by human cytomegalovirus. , 2009, Journal of the National Cancer Institute.
[74] A. Pinto,et al. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. , 2008, Cancer research.
[75] W. Duan,et al. Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc* , 2008, Journal of Biological Chemistry.
[76] C. Liu,et al. Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues. , 2008, Cancer letters.
[77] M. Bellon,et al. Regulation of telomerase and telomeres: human tumor viruses take control. , 2008, Journal of the National Cancer Institute.
[78] S. Kyo,et al. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. , 2007, Cancer research.
[79] C. Liu,et al. Mitogen-Activated Protein Kinase Cascade-Mediated Histone H3 Phosphorylation Is Critical for Telomerase Reverse Transcriptase Expression/Telomerase Activation Induced by Proliferation , 2006, Molecular and Cellular Biology.
[80] P. Ekman,et al. Differential Expression of Full-length Telomerase Reverse Transcriptase mRNA and Telomerase Activity between Normal and Malignant Renal Tissues , 2005, Clinical Cancer Research.
[81] W. Hahn,et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[82] T. Kiyono,et al. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. , 2004, Genes & development.
[83] L. Huang,et al. HIF‐1α induces cell cycle arrest by functionally counteracting Myc , 2004 .
[84] J. Ruppert,et al. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. , 2003, Gene.
[85] Yoshiki Murakami,et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene , 2003, Oncogene.
[86] E. Blennow,et al. Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome. , 2003, American Journal of Human Genetics.
[87] J F Barrett,et al. Arsenic inhibition of telomerase transcription leads to genetic instability. , 2001, The Journal of clinical investigation.
[88] J. Barrett,et al. cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. , 2001, Journal of the National Cancer Institute.
[89] S. Kyo,et al. Telomerase activation by histone deacetylase inhibitor in normal cells. , 2001, Nucleic acids research.
[90] Nikita Popov,et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[91] A. Zetterberg,et al. Frequent amplification of the telomerase reverse transcriptase gene in human tumors. , 2000, Cancer research.
[92] Robert A. Weinberg,et al. Creation of human tumour cells with defined genetic elements , 1999, Nature.
[93] M. Yutsudo,et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. , 1999, Cancer research.
[94] G. Hannon,et al. Myc activates telomerase. , 1998, Genes & development.
[95] C. Harley,et al. Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.
[96] Keiko Hiyama,et al. Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.
[97] Daniel L. Cameron,et al. TERT structural rearrangements in metastatic pheochromocytomas. , 2018, Endocrine-related cancer.
[98] J. Barrett,et al. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. , 2004, The EMBO journal.
[99] R. Glasspool,et al. Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3. , 2000, Neoplasia.
[100] Y. Cong,et al. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. , 1999, Human molecular genetics.